As coronavirus outbreak reaches 'tipping point,' GSK lends adjuvant tech to Chinese partner armed with preclinical vaccine
As the coronavirus originating out of Wuhan spreads to South Korea, Italy and Iran, stoking already intense fears of a pandemic, GlaxoSmithKline has found another …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.